USP General Notices and General Test Chapters: Interpretations and Misinterpretations

Publication
Article
Pharmaceutical TechnologyPharmaceutical Technology-10-02-2004
Volume 28
Issue 10

The authors dispel common misinterpretations of the United States Pharmacopeia.

External Link - article-128392.pdf

Articles in this issue
A Novel Freeze Pelletization Technique for Preparing Matix Pellets
Aseptic Processing: A Review of Current Industry Practice
Can Inserts Be Improved?
Analysis of a Kneading Process to Evaluate Drug Substance-Cyclodextrin Complexation
Drug Development Linked More Closely to Diagnostics
Preparation and In Vitro Characterization of Self-Nanoemulsified Drug Delivery Systems of Coenzyme Q10 Using Chiral Essential Oil Components
In The Spotlight-October 2004
October 2004
Visible-Residue Limit for Cleaning Validation and its Potential Application in Pharmaceutical Research Facility
The High Price of Success
Pharma Company Investment in Parenteral Manufacturing Capacity Picking Up
USP General Notices and General Test Chapters: Interpretations and Misinterpretations
Breaking the Barrier: Advances in Transdermal Technology
Recent Videos
Jens Schmidt, associate director MSAT at Lonza
Behind the Headlines episode 8
Related Content
TOP NEWS on grunge world map | Image Credit: © Sean K - stock.adobe.com

Pharmaceutical Industry Responds to Proposed Trump Administration Tariffs

Patrick Lavery
February 4th 2025
Article

The tariffs President Trump wants to levy against Canada and Mexico are on hold, for now, but China has already announced it intends to proceed with retaliatory tariffs against the US.

Drug Solutions Podcast: Growth and Advancements in Fill/Finish

Drug Solutions Podcast: Growth and Advancements in Fill/Finish

Felicity Thomas
June 25th 2024
Podcast

In this episode, Hanns-Christian Mahler from ten23 Health chats about the advances in fill/finish.

Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - © Artur - stock.adobe.com

Alvogen Recalls Fentanyl Transdermal System

Susan Haigney
February 3rd 2025
Article

The company is recalling one lot of Fentanyl Transdermal System 25 mcg/h transdermal patches because of possible multi-stacking of patches.

Drug Solutions Podcast: All About Data: Looking at the EHDS in More Detail

Drug Solutions Podcast: All About Data: Looking at the EHDS in More Detail

Felicity Thomas
May 28th 2024
Podcast

In this episode, Alexander Natz from EUCOPE chats about the European Health Data Space.

Question mark background | Image Credit: © Leigh-Prather - © Leigh Prather - stock.adobe.com

Regulations in AI and Other Digital Technologies

Siegfried Schmitt
January 31st 2025
Article

AI regulations in healthcare are rapidly evolving, and one should consult with regulatory subject matter experts, says Siegfried Schmitt, PhD, vice president, Technical at Parexel.

TOP NEWS on grunge world map | Image Credit: © Sean K - stock.adobe.com

Zentalis to Cut 40% of Workforce Under Strategic Restructuring Plan

Patrick Lavery
January 30th 2025
Article

The reduction is expected to be “substantially completed,” the San Diego-based company said, in the second quarter of 2025.